Yes, cancer genomics has the potential to aid in early detection and diagnosis. By analyzing genetic alterations in blood samples (liquid biopsies) or other bodily fluids, it is possible to detect cancer-related mutations before the disease becomes symptomatic. This approach is still in the research phase but holds promise for improving early diagnosis and, consequently, patient outcomes.
